isoform in active patients, suggest a stronger value of this isoform as a biomarker of disease activity. When we analyse the available variables between the patients that performed the PROs at home we found for both periods considered that they were younger (45,2/49,8 vs 53,4/55,1 p<0.001) they have more education (11.8/10.35 vs 8.2/ 7,9) no differences were found regarding gender. There is a tendency that with the continuous use of touchscreen computers at the day hospital less educated (T0 -11.8, T1-10.35 school years) and older patients (T0-45,2/ T1 -49,8 years) are using more at home platform of Reuma.pt.
Conclusions:
The use of technology could have a consider impact on the way we collected data from our patients. With the use of a touchscreen computer we have improved not only the overall completion of PROs but also increased the familiarity of patient to the online questionnaires. Number of appoitments with previous at home completion of the questionnaires more than double. This has a clear impact on patient participation, quality of data in the registry but even more impact on time and human resources at a day hospital. All patients filled in EQ-5D, RAPID-3 and HADS questionnaires during the first and the control visits at 12 months. Questionnaires' sensitivity was assessed by comparing patient's answers and objective response to therapy measured by achievement of complete regression of the nodules on the control visit. The construct validity was measured based on correlation with "external criteria", including presence of arthritis and arthralgias, tenderness of nodules at palpation measured by VAS, ESR and CRP values. Results: Positive dynamics (nodule regression) correlated with improved EQ-5D (EQ-5D-scale -p=0,005, EQ-5D-VAS -p=0,004) and RAPID-3 (p=0,0011). Median EQ-5D and HADS-depression after therapy were 0,27 [0,12; 0,45] (p=0,005), and 2 [1;5] (p=0,13) scores, respectively, while average decline in RAPID-3 and HADS-anxiety scores after therapy was 9,2±5,2 (p=0,0011) and 4±3 (p=0,15), respectively. EQ-5D showed the greatest power in Pn patients' quality of life assessment. EQ-5D-scale and VAS-"thermometer" showed moderate correlation with nodule tenderness at baseline (r= -0,23, p=0,036) & (r= -0,45, p=0,0003) , and control visits (12 months Objectives: To characterize and quantify systemic involvement at diagnosis in a large international cohort of patients with primary Sjögren's syndrome (SS). Methods: The Big Data Sjögren Project was formed in 2014 to take a "highdefinition" picture of primary SS at diagnosis by merging international databases (9302 consecutive patients from 21 countries of the 5 continents). The main features (including ESSDAI/DAS) at diagnosis were analysed. Results: Baseline ESSDAI was available in 8061 patients (93% female, mean age 53yrs). The mean ESSDAI score at diagnosis of the entire cohort was 6.4±7.9. In 1498 patients (19%), score at diagnosis was 0, while 681 (8%) presented with high activity in at least one domain. The main systemic features at diagnosis were biological (51%), articular (38%), haematological (24%) and glandular (22%). Low DAS was reported in 4480 (56%) patients, moderate DAS in 2483 (31%) and high DAS in 1098 (14%) patients. The mean baseline ESSDAI was higher the younger the patient was (p<0.001), higher in White patients (6.9 vs 5.1, p<0.001), males (8.4 vs 6.2, p<0.001), those with positive ocular (6.7 vs 4.9, p<0.001) or oral (6.8 vs 6.2, p=0.016) tests, and those with ANA (6.9 vs 4.5, p<0.001), RF (7.5 vs 5.8, p<0.001) and anti-Ro/La antibodies (7.2 vs 4.4, p<0.001). Logistic regression identified as independent variables White ethnicity (OR 3.07), abnormal ocular tests (OR 2.14), ANA (OR 1.67) and Ro/La autoantibodies (OR 2.78). Conclusions: This is the largest series of patients with primary SS in whom the ESSDAI score has been evaluated. Primary SS is undeniably a systemic disease even at the time of diagnosis, with nearly 80% of patients showing an ESSDAI score >0. Background: Patient reported outcome measures are comprised of either sets of questionnaires or patient global assessment based on visual analogue scale (VAS). These patient-reported outcome measures lack accuracy and/or clinical feasibility when comparing heterogeneous patient groups with different diseases, or when characterizing patients with systemic disease involving different organ systems. Objectives: Developing a clinical feasible patient-reported outcome measure based VAS assessment of different organ systems. Methods: Patients were asked to rate their health status in a 10cm VAS (0-100%) concerning their global health as well as of different organ systems, namely heart, lung, muscle and joints, gastro-intestinal, metabolic, uro-genital, skin, neuro-psychiatric, eyes and ears. All VA-scales were "anchored". Patients were advised to rate their health status below 75% if they felt "medical action is needed", they should rate the health status <50% in case of a "strong need for medical action" and <25% in case of a "medical emergency". 336 patients from different outpatient clinics (cardiologic, pneumologic, gastrointestinal, nephrologic, neurologic, dermatologic, rheumatologic, ophthalmologic and obesity outpatient clinic) as well as patients from internal emergency clinics and a general practitioner clinic were evaluated. Both, patients and the attending physicians completed the Popgen-OSSA. In addition the attending physician was asked to document ranking of the 5 most important diagnoses of the patient. Statistical analysis was carried out using non-parametric testing. Furthermore, to predict main diagnoses based on patients's as well as physician's OSSA state-of-the-art machine learning tools, namely support vector machines (SVMs), were applied. To assess model performance multi-class AUC (area under the ROC curve) according to Hand and Till (2001) was estimated based on repeated cross validation (10 folds, 5 repeats), optimizing the SVM's hyperparamters using grid search. Results: The test showed a good reproducibility. With a mean percentage of 74±0.98 SE and 66±1.17 SE, respectively, the physicians OSSA rating was significantly higher than the rating of the patients (p wilcoxon <0.001). Models predicting main diagnoses were constructed and estimated to perform with multi-class AUCs of 63.5% and 73.4% based on patient's and physician's OSSA, respectively. Conclusions: In this preliminary trial with low sample size the Popgen-OSSA showed a good reproducibility and allowed a correct allocation of the patient's clinical problem to involved organ system by SVM analysis with multi-class AUC of up to 73.4%. These data merit further investigation and development of the Popgen-OSSA on larger patient cohorts. 
